In Chicago, Jeffrey Hubbell, a Professor of Molecular Engineering Innovation and Enterprise at the University of Chicago, received the Society for Biomaterials’ 2017 Founders Award. Hubbell’s immunotherapy work focuses on designing biomaterials for stimulating the immune system, fighting infections, and even shutting off some autoimmune responses that cause diseases like Type 1 diabetes. Hubbell has co-founded five companies including ClostraBio, a food allergy treatment startup, Kuros Biosciences, a developer of biomaterials technology for surgical sealants, QGel, a developer of biomaterials for cell cultures, Anokion, a developer of autoimmune technology, and Kanyos Bio, a tech developer for Type 1 diabetes and celiac disease. The award is given every year to someone who, according to the University of Chicago, has made “long-term, landmark contributions to the discipline of biomaterials.”
Home Biomaterials Society for Biomaterials Awards 2017 Founders Award to University of Chicago Professor
Latest article
Neste reduces focus on renewable chemicals
In Finland, oil company Neste has announced a performance improvement program that includes deemphasizing renewable chemicals. The company cites a significantly changed market environment...
LSU team envisions Fat Tuesday without the waste
In Baton Rouge, a team at Louisiana State University is hoping to scale production of biodegradable, seed-infused Mardi Gras beads to make the state’s...
Edelrid introduces castor oil-based climbing rope
In Germany, mountaineering equipment firm Edelrid has introduced climbing rope made from castor oil.
Birdlime 1R 9.8 climbing rope uses polyamide-11 made from castor oil...